Detailed price information for Johnson & Johnson (JNJ-N) from The Globe and Mail including charting and trades.

Gilead Sciences announced a significant milestone ... As the fight against HIV evolves, our high-quality antigens empower researchers, vaccine developers, and diagnostic innovators to stay ...

The global CAR T-cell therapy market is projected to grow from USD 2.7 billion in 2025 to over USD 27.5 billion by 2033, reflecting a robust CAGR of 26.2%.

Robb DeFilippis, managing director, life sciences, for end-to-end global creative ... calls-to-action, legal copy and logos, and the content can then be used as a framework for messages.

Riyadh, October 12, 2022, SPA -- King Faisal Specialist Hospital & Research Center (KFSHRC) has signed a memorandum of understanding with Kite-Gilead ... high quality within an environment of an ...

Gilead Sciences Inc. CEO Daniel O'Day's compensation rose 4.8% last year to $23.7 million — roughly $97 for every buck made ...

Rating: Analysts assign qualitative assessments to stocks, ranging from 'Outperform' to 'Underperform'. These ratings convey the analysts' expectations for the relative performance of Gilead Sciences ...

Investors with a lot of money to spend have taken a bearish stance on Gilead Sciences GILD. And retail traders should know.

Have you been paying attention to shares of Gilead Sciences (GILD)? Shares have been on the move with the stock up 17.1% over the past month. The stock hit a new 52-week high of $117.39 in the ...